(Q34469018)

English

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

phase I clinical trial

0 references

0 references

0 references

Orthoebolavirus zairense

0 references

1 reference

based on heuristic

inferred from title

vector-based vaccine

1 reference

based on heuristic

inferred from title

People's Republic of China

0 references

author name string

Feng-Cai Zhu

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Li-Hua Hou

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jing-Xin Li

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Shi-Po Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Pei Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gui-Rong Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Yue-Mei Hu

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Fan-Yue Meng

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jun-Jie Xu

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Rong Tang

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jin-Long Zhang

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Wen-Juan Wang

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lei Duan

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kai Chu

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Qi Liang

15

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jia-Lei Hu

16

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Li Luo

17

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Tao Zhu

18

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jun-Zhi Wang

19

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Wei Chen

20

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

25 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

385

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

9984

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2272-2279

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging diseases. On the trail of Ebola and Marburg viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Marburg and Ebola viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of Zaire Ebola Virus Disease in Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

CD69 guides CD4+ T cells to the seat of memory

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: identification of lupus anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960553-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(15)60553-0

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34469018&oldid=1749483476"